 |
SigmaPharm LABORATORIES |
- | Home |
- About Us |
- Management |
- News |
- Products |
- Facilities |
- Contact Us |
News
July 2010
- Sigmapharm receives approval from FDA for its third product - Ergocalciferol Capsules, USP 1.25 mg (equivalent to 50,000 USP units of Vitamin D).
June 2010
- Sigmapharm files its 7th Abbreviated New Drug Application which contains a paragraph IV certification. This is the company's first paragraph IV filing.
- Sigmapharm files its first Drug Master File (DMF).
May 2010
- Sigmapharm receives approval from FDA for its second product - Protriptyline HCl Tablets, USP 5 mg & 10 mg.
February 2010
- Sigmapharm files its 6th Abbreviated New Drug Application.
September 2009
- Sigmapharm passes its second FDA inspection.
- Sigmapharm files its 5th Abbreviated New Drug Application.
July 2009
- Sigmapharm files its 4th Abbreviated New Drug Application.
April 2009
- Sigmapharm launches its first product, Amiloride HCl Tablets, USP 5 mg, for commercial marketing
through Rising Pharmaceuticals, Inc.
January 2009
- Sigmapharm receives approval from FDA for its first product - Amiloride HCl Tablets, USP 5 mg.
November 2008
- Sigmapharm files its 3rd Abbreviated New Drug Application.
May 2008
- Sigmapharm files its 2nd Abbreviated New Drug Application.
January 2008
- Sigmapharm passes its first FDA inspection.
June 2007
- Sigmapharm files its 1st Abbreviated New Drug Application.
August 2006
- Sigmapharm moves to a new 60,000 sq. ft. facility in Bensalem, Pennsylvania.